Low-dose rosiglitazone plus metformin reduces risk of incident type 2 diabetes compared with placebo in people with impaired glucose tolerance
- Resource Type
- Academic Journal
- Source
- Evidence Based Medicine. Feb 01, 2011 16(1):10-11
- Subject
- Language
- English
- ISSN
- 1356-5524